Sponsor

Glenmark Pharmaceuticals S.A.

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Glenmark Pharmaceuticals S.A. appears in 5 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials5
Recruiting shown0
Roles1
SourceClinicalTrials.gov
Advertisement

Clinical trials

5 shown
Study of ISB 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast CancerNCT03983395 · collaborator · 2020-04-08
TERMINATED
A Clinical Trial to Study the Effects GRC 17536 in Patients With Painful Diabetic Peripheral Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients).NCT01726413 · collaborator · 2012-11-01
COMPLETED
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent AsthmaNCT01436890 · collaborator · 2011-10-01
COMPLETED
A Clinical Trial to Study the Effects of Revamilast in Patients With Rheumatoid ArthritisNCT01430507 · collaborator · 2011-09-01
COMPLETED
A Clinical Trial to Study the Effects of GRC 17536 in Patients With Painful Diabetic Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients)NCT01556152 · collaborator
WITHDRAWN

Sponsor roles

collaborator5

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.